Twenty years of experience building and running SMEs. Extensive C-level experience leading complex M&A transactions, fundraising and business development in multiple global jurisdictions. Seven years capital markets experience at Credit Suisse First Boston and BNP Paribas.  Formerly founder and  CEO of Hawkley Oil and Gas, MD of Hallwood Oil and Gas. BSc Chemistry (Hons) from the University of Kent, MBA (Finance) from London Business School.

Two decades of international leadership in operational and commercial capacities within the pharmaceutical sector, with twelve years of C-level expertise. Demonstrated expertise in managing the development and distribution of a diverse range of products in multiple global pharma markets. Significant roles at leading pharmaceutical firms such as Veriton Pharma Ltd, Novo Nordisk, UCB Pharma, and Pfizer.

Twenty years’ Supply Chain experience across multiple industries, ten years in Pharmaceuticals. Successfully delivered numerous transformation projects using Lean principles, Certified Lean Black Belt. Held leadership roles in industry-leading and blue-chip companies such as Veriton Pharma, Honeywell Aerospace and PCI Pharma Services.

Brings twenty years of capital markets and institutional experience from senior roles at RBC Capital Markets, Dresdner Kleinwort, and as a multi-asset portfolio manager to Green Park's strategic partnerships and business development. Leads partnership strategy and commercial due diligence for new opportunities. Manages relationships with institutional investors, family offices, and funding bodies. His quantitative background and analytical experience help bridge clinical innovation with commercial viability.

Thirty years’ experience in financial markets comprising over 20 years of senior management roles - the last of which was at Royal Bank of Canada in Europe. Upon leaving the corporate world, he co-founded an asset management business and is a managing partner of a co investment office which supports companies focusing on technology for global impact.

Thirty years experience in the UK Pharma industry, including General Management at Cephalon UK and board-level marketing positions with Novo Nordisk and Sanofi. Has led the successful launch of seven major branded pharma products. Most recently, he was an independent consultant to industry majors, advising on product launches and their successful adoption within the NHS. ​​​

Seasoned pharmaceutical product development expert with extensive experience developing various dosage forms. Proven ability to navigate complex regulatory landscapes and bring projects to fruition through achievement of market authorisations.  PhD from King’s College London in Biochemistry. Former CSO at Veriton Pharma where she took a key product through to a granted license and is named on two patents, former Director of Pharmaceutical Development at MedPharm Ltd where she lead key teams to develop pharmaceutical products for inhalation, topical and ophthalmic routes.

A Chartered Accountant with 30 years' experience, with a broad range of financial and commercial skills gained at TT Electronics plc, Greenshields JCB and most recently at Veriton Pharma. Since joining Green Park, Bill has worked to establish policies and procedures that will ensure sound financial management of the business and help support the company's future growth.

A highly focussed Commercial Director with thirty years of experience in the pharmaceutical industry, leading teams and launching multiple products in the UK. A wealth of commercial expertise focussed heavily on both the management of national and regional UK tenders as well as leading teams within the NHS and private hospital sectors. A highly effective communicator with a broad depth of critical NHS contacts, both clinical and purchasing.

A patent attorney with thirty years’ experience in the field of intellectual property, having supported startups through to the biggest global biopharma companies, leading projects on numerous blockbuster drugs. He is Senior Partner at Carpmaels & Ransford and a Partner in the Life Sciences team. He is recognised in all the leading legal directories, including as an Eminent Practitioner by Chambers, and this year entered Legal 500’s Hall of Fame. MBiochem (Hons), D. Phil, both at the University of Oxford.